Impact of Highly Active Antiretroviral Therapy (HAART) on Some Immunological Indices and Quality of Life of HIV Positive Patients in Africa
HIV infection is one of the most widespread pandemics, with an estimated 79.3 million people infected worldwide. It posed a threat to humanity’s survival due to its high mortality and morbidity. This was before the development of an efficient virus-replication-inhibiting medication. HAART, or highly effective antiretroviral therapy, is a...
Read More
Liver Enzymes and HIV-infected Adults on HARRT: Evidence from a Randomised Cross-sectional Study in UPTH
This research looked at the levels of liver enzymes in HIV-infected adults who had been on highly active antiretroviral therapy (HAART) for at least a year. The study was planned as a randomised cross-sectional study to compare the aspartate aminotransferase [AST], alanine transaminase [ALT], and alkaline phosphatase [ALP] levels...
Read More
A Study on Cytomegalovirus Infection among Human Immunodeficiency Virus (HIV) Infected Individuals on Highly Active Anti-retroviral Therapy in North-Central Nigeria
Background: Cytomegalovirus (CMV) infection is common among HIV-infected individuals. Its contribution to morbidity and mortality became more apparent following introduction of highly active antiretroviral therapy (HAART) which improved survival among HIV-infected individuals. Objectives: This study aimed at determining the prevalence of both active and latent CMV infections among HIV-infected...
Read More